Neo Ivy Capital Management Laboratory Corp Of America Holdings Transaction History

Neo Ivy Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	BUY	$201.05 - $221.7 $956,998 - $1.06 Million	4,760 New	4,760 $957,000
Q4 2022 Mar 24, 2023	BUY	$203.72 - $248.97 $1.02 Million - $1.25 Million	5,012 Added 5331.91%	5,106 $1.2 Million
Q3 2022 Nov 15, 2022	BUY	$204.81 - $262.19 $19,252 - $24,645	94 New	94 $19,000
Q1 2021 Oct 07, 2021	SELL	$204.88 - $255.03 $202,626 - $252,224	-989 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $51,213 - $58,751	-274 Reduced 21.69%	989 $201,000
Q1 2020 May 15, 2020	BUY	$104.32 - $195.28 $100,460 - $188,054	963 Added 321.0%	1,263 $160,000
Q4 2019 Feb 13, 2020	BUY	$163.48 - $173.61 $49,044 - $52,083	300 New	300 $51,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.